Evidence map›Paper›PMID 29593045›Full record

ArticleJournal of virology2018

Degradation of a Novel DNA Damage Response Protein, Tankyrase 1 Binding Protein 1, following Adenovirus Infection.

Nafiseh Chalabi Hagkarim, Ellis L Ryan, Philip J Byrd, Robert Hollingworth, Neil J Shimwell, Angelo Agathanggelou, Manon Vavasseur, Viktoria Kolbe, Thomas Speiseder, Thomas Dobner and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of virology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Nafiseh Chalabi Hagkarim *Institute of Cancer and Genomic Sciences, College of Medicine and Dentistry, University of Birmingham, Birmingham, United Kingdom.
Ellis L Ryan *Institute of Cancer and Genomic Sciences, College of Medicine and Dentistry, University of Birmingham, Birmingham, United Kingdom.
Philip J ByrdInstitute of Cancer and Genomic Sciences, College of Medicine and Dentistry, University of Birmingham, Birmingham, United Kingdom.
Robert HollingworthInstitute of Cancer and Genomic Sciences, College of Medicine and Dentistry, University of Birmingham, Birmingham, United Kingdom.
Neil J ShimwellInstitute of Cancer and Genomic Sciences, College of Medicine and Dentistry, University of Birmingham, Birmingham, United Kingdom.
Angelo AgathanggelouInstitute of Cancer and Genomic Sciences, College of Medicine and Dentistry, University of Birmingham, Birmingham, United Kingdom.
Manon VavasseurInstitute of Cancer and Genomic Sciences, College of Medicine and Dentistry, University of Birmingham, Birmingham, United Kingdom.
Viktoria KolbeHeinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany.
Thomas SpeisederHeinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany.
Thomas DobnerHeinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany.
Grant S StewartInstitute of Cancer and Genomic Sciences, College of Medicine and Dentistry, University of Birmingham, Birmingham, United Kingdom g.s.stewart@bham.ac.uk r.j.a.grand@bham.ac.uk.
Roger J GrandInstitute of Cancer and Genomic Sciences, College of Medicine and Dentistry, University of Birmingham, Birmingham, United Kingdom g.s.stewart@bham.ac.uk r.j.a.grand@bham.ac.uk.
University of Birmingham · GBLeibniz Institute of Virology (LIV) · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infection by most DNA viruses activates a cellular DNA damage response (DDR), which may be to the detriment or advantage of the virus. In the case of adenoviruses, they neutralize antiviral effects of DDR activation by targeting a number of proteins for rapid proteasome-mediated degradation. We have now identified a novel DDR protein, tankyrase 1 binding protein 1 (TNKS1BP1) (also known as Tab182), which is degraded during infection by adenovirus serotype 5 and adenovirus serotype 12. In both cases, degradation requires the action of the early region 1B55K (E1B55K) and early region 4 open reading frame 6 (E4orf6) viral proteins and is mediated through the proteasome by the action of cullin-based cellular E3 ligases. The degradation of Tab182 appears to be serotype specific, as the protein remains relatively stable following infection with adenovirus serotypes 4, 7, 9, and 11. We have gone on to confirm that Tab182 is an integral component of the CNOT complex, which has transcriptional regulatory, deadenylation, and E3 ligase activities. The levels of at least 2 other members of the complex (CNOT3 and CNOT7) are also reduced during adenovirus infection, whereas the levels of CNOT4 and CNOT1 remain stable. The depletion of Tab182 with small interfering RNA (siRNA) enhances the expression of early region 1A proteins (E1As) to a limited extent during adenovirus infection, but the depletion of CNOT1 is particularly advantageous to the virus and results in a marked increase in the expression of adenovirus early proteins. In addition, the depletion of Tab182 and CNOT1 results in a limited increase in the viral DNA level during infection. We conclude that the cellular CNOT complex is a previously unidentified major target for adenoviruses during infection.

Indexed as

AdenoviridaeAdenoviridae InfectionsAdenovirus E4 ProteinsCullin ProteinsExoribonucleasesHEK293 CellsHeLa CellsHumansProteasome Endopeptidase ComplexProteolysisRepressor ProteinsSerogroupTelomeric Repeat Binding Protein 1Transcription FactorsViral ProteinsAdenovirus E4 ProteinsCNOT1 protein, humanCNOT4 protein, humanCNOT7 protein, humanCullin ProteinsE1B55K protein, adenovirusE4orf6 protein, adenovirusExoribonucleasesProteasome Endopeptidase ComplexRepressor ProteinsTelomeric Repeat Binding Protein 1TNKS1BP1 protein, humanTranscription FactorsViral ProteinsAdE1B55Kadenovirus E1B55KadenovirusesCNOT1CNOT complexTab182TNKS1BP1

Identifiers

PMID29593045
PMCPMC5974482
OpenAlexW2794806522

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.